Article Details
Retrieved on: 2024-04-19 18:59:21
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details the expected growth of the mRNA therapeutics market to $45.85 billion by 2031, driven by mRNA vaccine success against COVID-19. North America leads the market, while companies like Moderna and Pfizer, which collaborated with BioNTech, show significant revenue from mRNA vaccines. Challenges include economic impacts, manufacturing scalability, and regulatory complexity.
Article found on: www.digitaljournal.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here